Drug Shortage Report for RANITIDINE
Report ID | 120753 |
Drug Identification Number | 00740748 |
Brand name | RANITIDINE |
Common or Proper name | RANITIDINE -150 |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60,500 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-07-22 |
Estimated end date | Unknown |
Actual end date | 2023-07-10 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-22 | English | Compare |
v2 | 2020-07-22 | French | Compare |
v3 | 2020-07-23 | English | Compare |
v4 | 2023-07-11 | English | Compare |
v5 | 2023-07-11 | French | Compare |
Showing 1 to 5 of 5